Improvements in sensitivity, specificity, and accurate quantitation allow researchers to glean valuable information from hundreds of samples in record time.
Clinical and translational research is increasingly turning to molecular studies, such as proteomics and metabolomics, but research is limited by the availability of tools to catalog the many thousands of molecules in a single blood sample with high accuracy, sensitivity, and speed.
Mass spectrometry can provide quantitative peptide-level information, but until recently has lacked the throughput to accommodate large-scale studies.
Author's summary: Mass spec boosts multiomics research.